4.7 Article

Three-dimensional human neural culture on a chip recapitulating neuroinflammation and neurodegeneration

期刊

NATURE PROTOCOLS
卷 18, 期 9, 页码 2838-2867

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41596-023-00861-4

关键词

-

向作者/读者索取更多资源

This article describes a protocol for fabricating a microfluidic device and using it in three-dimensional human neural cultures to study neuron-glia interactions in neuroinflammation and neurodegeneration. The device can replicate pathological features of major neurological disorders and reveal the mechanisms of neuro-glia interactions. The protocol requires training in basic molecular biology techniques.
Protocol for the fabrication of a microfluidic device and its implementation in three-dimensional human neural cultures, allowing the study of neuron-glia interactions in neuroinflammation and neurodegeneration. Neuroinflammation has either beneficial or detrimental effects, depending on risk factors and neuron-glia interactions in neurological disorders. However, studying neuroinflammation has been challenging due to the complexity of cell-cell interactions and lack of physio-pathologically relevant neuroinflammatory models. Here, we describe our three-dimensional microfluidic multicellular human neural culture model, referred to as a 'brain-on-a-chip' (BoC). This elucidates neuron-glia interactions in a controlled manner and recapitulates pathological signatures of the major neurological disorders: dementia, brain tumor and brain edema. This platform includes a chemotaxis module offering a week-long, stable chemo-gradient compared with the few hours in other chemotaxis models. Additionally, compared with conventional brain models cultured with mixed phenotypes of microglia, our BoC can separate the disease-associated microglia out of heterogeneous population and allow selective neuro-glial engagement in three dimensions. This provides benefits of interpreting the neuro-glia interactions while revealing that the prominent activation of innate immune cells is the risk factor leading to synaptic impairment and neuronal loss, validated in our BoC models of disorders. This protocol describes how to fabricate and implement our human BoC, manipulate in real time and perform end-point analyses. It takes 2 d to set up the device and cell preparations, 1-9 weeks to develop brain models under disease conditions and 2-3 d to carry out analyses. This protocol requires at least 1 month training for researchers with basic molecular biology techniques. Taken together, our human BoCs serve as reliable and valuable platforms to investigate pathological mechanisms involving neuroinflammation and to assess therapeutic strategies modulating neuroinflammation in neurological disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据